Constipation Treatment Global Market Opportunities And Strategies To 2034

Description

Constipation treatment refers to the range of medical, dietary and behavioral interventions used to relieve infrequent, difficult, or incomplete bowel movements. Treatments may include laxatives, stool softeners, fiber supplements, prokinetic agents, or osmotic solutions, as well as lifestyle modifications such as increased water intake, physical activity and dietary fiber consumption. The primary purpose of constipation treatment is to restore normal bowel function, improve digestive health and alleviate discomfort associated with hard or infrequent stools.

The global constipation treatment market reached a value of nearly $11,724.44 million in 2024, having grown at a compound annual growth rate (CAGR) of 6.06% since 2019. The market is expected to grow from $11,724.44 million in 2024 to $17,313.37 million in 2029 at a rate of 8.11%. The market is then expected to grow at a CAGR of 7.59% from 2029 and reach $24,964.49 million in 2034.

Changing Dietary Patterns

During the historic period, the constipation treatment market was mainly driven by changing dietary patterns. The increasing consumption of ultra-processed foods, coupled with a decline in fiber intake and irregular eating habits, has significantly affected gastrointestinal health, leading to a higher prevalence of constipation worldwide. These dietary shifts have disrupted gut motility and microbiota balance, increasing the need for therapeutic interventions. Moreover, as populations transitioned from traditional diets rich in whole grains, fruits and vegetables to Westernized diets dominated by convenience and processed foods, the incidence of chronic constipation rose substantially. For instance, in June 2025, according to National Diet and Nutrition Survey (NDNS) conducted by Office for Health Improvement & Disparities, a government unit within the Department of Health and Social Care in England, from 2019 to 2023, most participants did not meet the UK government recommendation to eat at least 5 portions of a variety of fruit and vegetables each day. In addition to this, most people do not meet the UK government fibre recommendations (at least 30g per day for adults and 15 to 25g per day for children depending on their age). For younger children, 78% of those aged 18 months to 3 years and 86% of those aged 4 to 10 years did not meet the recommendation for their age group. For children aged 11 to 18 years and for adults, 96% did not meet the fibre recommendation. Therefore, the constipation treatment market was mainly driven by changing dietary patterns.

Expansion Of Targeted Therapies To Address Opioid-Induced Constipation (OIC)

Major players in the constipation treatment market are increasingly seeking regulatory approval and market access for novel therapies addressing opioid-induced constipation (OIC), a condition often overlooked despite its high prevalence. These efforts focus on enhancing patient quality of life (QOL) and filling gaps where standard treatments such as laxatives may be inadequate. For instance, in May 2025, Shionogi & Co., Ltd., a Japan-based global pharmaceutical firm, announced that a New Drug Application (NDA) for Naldemedine, a treatment for OIC, had been accepted in China. This application is intended to contribute to better constipation care by providing a dedicated pharmacologic option in a market where treatment was largely symptomatic and supportive. By advancing naldemedine into the Chinese regulatory pathway, Shionogi aims to advance its gastrointestinal portfolio and capitalise on the growing demand for targeted OIC therapies in Asia.

The global constipation treatment markets is fragmented, with large number of small players operating in the market. The top 10 competitors in the market made up 21.10% of the total market in 2024.

Constipation Treatment Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global constipation treatment market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for constipation treatment? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The constipation treatment market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider constipation treatment market; and compares it with other markets.

The report covers the following chapters

Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by therapeutic types, by disease type and by distribution channel.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by therapeutic types, by disease type and by distribution channel in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size And Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Recent Developments- Information on recent developments in the market covered in the report.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for constipation treatment providers in terms of product/service offerings geographic expansion, marketing strategies and target groups
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Therapeutic Types: Laxatives; Chloride Channel Activators; Peripherally Acting Mu-Opioid Receptor Antagonists; GC-C (Guanylate Cyclase-C) Agonists; Other Therapeutics
2) By Disease Type: Chronic Idiopathic Constipation (CIC); Irritable Bowel Syndrome with Constipation (IBS-C); Opioid-Induced Constipation (OIC)
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Companies Mentioned: AbbVie Inc.; Bausch Health Companies Inc. (TRULANCE); Ironwood Pharmaceuticals Inc. (LINZESS); Ardelyx Inc.; Procter & Gamble
Countries: Australia; China; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; constipation treatment indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: HS6MCTRE04_O25Q4

1 Executive Summary

1.1 Constipation Treatment - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 Constipation Treatment Market Definition And Segmentations
6.4 Market Segmentation By Therapeutic Types
- 6.4.1 Laxatives
- 6.4.2 Chloride Channel Activators
- 6.4.3 Peripherally Acting Mu-Opioid Receptor Antagonists (PAMORAs)
- 6.4.4 GC-C (Guanylate Cyclase-C) Agonists
- 6.4.5 Other Therapeutics
6.5 Market Segmentation By Disease Type
- 6.5.1 Chronic Idiopathic Constipation (CIC)
- 6.5.2 Irritable Bowel Syndrome with Constipation (IBS-C)
- 6.5.3 Opioid-Induced Constipation (OIC)
6.6 Market Segmentation By Distribution Channel
- 6.6.1 Hospital Pharmacies
- 6.6.2 Retail Pharmacies
- 6.6.3 Online Pharmacies

7 Major Market Trends

7.1 Expansion Of Targeted Therapies To Address Opioid-Induced Constipation (OIC)
7.2 Advancement Of Diagnostic Devices To Improve Chronic Constipation Assessment And Patient Stratification
7.3 Launch Of Enhanced Treatment To For Constipation Management
7.4 Introduction Of Natural Fibre-Based Formulations To Meet Growing Demand For Gentle Digestive Health Solutions
7.5 Expansion Of Pediatric Treatment Indications To Address Unmet Needs In Childhood Constipation Management
7.6 Regulatory Advancements Driving Portfolio Diversification In Chronic And IBS-Related Constipation Therapies

8 Constipation Treatment Growth Analysis And Strategic Analysis Framework

8.1 Global Constipation Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
- 8.1.1 Political
- 8.1.2 Economic
- 8.1.3 Social
- 8.1.4 Technological
- 8.1.5 Environmental
- 8.1.6 Legal
8.2 Analysis Of End User (B2B And B2C) Market
- 8.2.1 Hospitals
- 8.2.2 Specialty Clinics
- 8.2.3 Homecare Settings
- 8.2.4 Retail Pharmacies
- 8.2.5 Other End-users (Online Pharmacies, Ambulatory Surgical Centers, Long-term Care Centers, Research and Academic Institutions)
8.3 Constipation Treatment Market Growth Rate Analysis
8.4 Global Historic Market Growth, 2019 - 2024, Value ($ Million)
- 8.4.1 Market Drivers 2019 - 2024
- 8.4.2 Market Restraints 2019 - 2024
8.5 Global Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
8.6 Forecast Growth Contributors/Factors
- 8.6.1 Quantitative Growth Contributors
- 8.6.2 Drivers
- 8.6.3 Restraints
8.7 Constipation Treatment Total Addressable Market (TAM)
- 8.7.1 TAM Comparison Analysis

9 Constipation Treatment Market Segmentation

9.1 Global Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.2 Global Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.3 Global Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.4 Global Constipation Treatment Market, Sub-Segmentation Of Laxatives, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.5 Global Constipation Treatment Market, Sub-Segmentation Of Chloride Channel Activators, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.6 Global Constipation Treatment Market, Sub-Segmentation Of Peripherally Acting Mu-Opioid Receptor Antagonists (PAMORAs), By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.7 Global Constipation Treatment Market, Sub-Segmentation Of GC-C (Guanylate Cyclase-C) Agonists, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.8 Global Constipation Treatment Market, Sub-Segmentation Of Other Therapeutics, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Constipation Treatment Market, Regional and Country Analysis

10.1 Constipation Treatment Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.2 Constipation Treatment Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

11.1 Summary
11.2 Market Overview
- 11.2.1 Region Information
- 11.2.2 Market Information
- 11.2.3 Background Information
- 11.2.4 Government Initiatives
- 11.2.5 Regulations
- 11.2.6 Regulatory Bodies
- 11.2.7 Major Associations
- 11.2.8 Taxes Levied
- 11.2.9 Corporate Tax Structure
- 11.2.10 Investments
- 11.2.11 Major Companies
11.3 Asia-Pacific Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.4 Asia-Pacific Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.5 Asia-Pacific Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.6 China Market
11.7 Summary
11.8 Market Overview
- 11.8.1 Country Information
- 11.8.2 Market Information
- 11.8.3 Background Information
- 11.8.4 Government Initiatives
- 11.8.5 Regulations
- 11.8.6 Regulatory Bodies
- 11.8.7 Major Associations
- 11.8.8 Taxes Levied
- 11.8.9 Corporate Tax Structure
- 11.8.10 Investments
- 11.8.11 Major Companies
11.9 China Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.10 China Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.11 China Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.12 India Market
11.13 India Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.14 India Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.15 India Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.16 Japan Market
11.17 Summary
11.18 Market Overview
- 11.18.1 Country Information
- 11.18.2 Market Information
- 11.18.3 Background Information
- 11.18.4 Government Initiatives
- 11.18.5 Regulations
- 11.18.6 Regulatory Bodies
- 11.18.7 Major Associations
- 11.18.8 Taxes Levied
- 11.18.9 Corporate Tax Structure
- 11.18.10 Investments
- 11.18.11 Major Companies
11.19 Japan Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.20 Japan Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.21 Japan Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.22 Australia Market
11.23 Australia Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.24 Australia Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.25 Australia Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.26 Indonesia Market
11.27 Indonesia Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.28 Indonesia Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.29 Indonesia Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.30 South Korea Market
11.31 Summary
11.32 Market Overview
- 11.32.1 Country Information
- 11.32.2 Market Information
- 11.32.3 Background Information
- 11.32.4 Government Initiatives
- 11.32.5 Regulations
- 11.32.6 Regulatory Bodies
- 11.32.7 Major Associations
- 11.32.8 Taxes Levied
- 11.32.9 Corporate Tax Structure
- 11.32.10 Major Companies
11.33 South Korea Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.34 South Korea Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.35 South Korea Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

12.1 Summary
12.2 Market Overview
- 12.2.1 Region Information
- 12.2.2 Market Information
- 12.2.3 Background Information
- 12.2.4 Government Initiatives
- 12.2.5 Regulations
- 12.2.6 Regulatory Bodies
- 12.2.7 Major Associations
- 12.2.8 Taxes Levied
- 12.2.9 Corporate tax structure
- 12.2.10 Investments
- 12.2.11 Major Companies
12.3 Western Europe Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.4 Western Europe Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.5 Western Europe Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.6 Western Europe Constipation Treatment Market: Country Analysis
12.7 UK Market
12.8 UK Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.9 UK Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.10 UK Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.11 Germany Market
12.12 Germany Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.13 Germany Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.14 Germany Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.15 France Market
12.16 France Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.17 France Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.18 France Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.19 Italy Market
12.20 Italy Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.21 Italy Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.22 Italy Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.23 Spain Market
12.24 Spain Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.25 Spain Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.26 Spain Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

13.1 Summary
13.2 Market Overview
- 13.2.1 Region Information
- 13.2.2 Market Information
- 13.2.3 Background Information
- 13.2.4 Government Initiatives
- 13.2.5 Regulations
- 13.2.6 Regulatory Bodies
- 13.2.7 Major Associations
- 13.2.8 Taxes Levied
- 13.2.9 Corporate Tax Structure
- 13.2.10 Major companies
13.3 Eastern Europe Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.4 Eastern Europe Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.5 Eastern Europe Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.6 Eastern Europe Constipation Treatment Market: Country Analysis
13.7 Russia Market
13.8 Russia Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.9 Russia Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.10 Russia Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

14.1 Summary
14.2 Market Overview
- 14.2.1 Region Information
- 14.2.2 Market Information
- 14.2.3 Background Information
- 14.2.4 Government Initiatives
- 14.2.5 Regulations
- 14.2.6 Regulatory Bodies
- 14.2.7 Major Associations
- 14.2.8 Taxes Levied
- 14.2.9 Corporate Tax Structure
- 14.2.10 Investments
- 14.2.11 Major Companies
14.3 North America Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.4 North America Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.5 North America Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.6 North America Constipation Treatment Market: Country Analysis
14.7 USA Market
14.8 Summary
14.9 Market Overview
- 14.9.1 Country Information
- 14.9.2 Market Information
- 14.9.3 Background Information
- 14.9.4 Government Initiatives
- 14.9.5 Regulations
- 14.9.6 Regulatory Bodies
- 14.9.7 Major Associations
- 14.9.8 Taxes Levied
- 14.9.9 Corporate Tax Structure
- 14.9.10 Investments
- 14.9.11 Major Companies
14.10 USA Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.11 USA Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.12 USA Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.13 Canada Market
14.14 Summary
14.15 Market Overview
- 14.15.1 Country Information
- 14.15.2 Market Information
- 14.15.3 Background Information
- 14.15.4 Government Initiatives
- 14.15.5 Regulations
- 14.15.6 Regulatory Bodies
- 14.15.7 Major Associations
- 14.15.8 Taxes Levied
- 14.15.9 Corporate Tax Structure
- 14.15.10 Investments
- 14.15.11 Major Companies
14.16 Canada Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.17 Canada Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.18 Canada Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

15.1 Summary
15.2 Market Overview
- 15.2.1 Region Information
- 15.2.2 Market Information
- 15.2.3 Background Information
- 15.2.4 Government Initiatives
- 15.2.5 Regulations
- 15.2.6 Regulatory Bodies
- 15.2.7 Major Associations
- 15.2.8 Taxes Levied
- 15.2.9 Corporate Tax Structure
- 15.2.10 Major Companies
15.3 South America Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.4 South America Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.5 South America Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.6 South America Constipation Treatment Market: Country Analysis
15.7 Brazil Market
15.8 Brazil Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.9 Brazil Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.10 Brazil Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

16.1 Summary
16.2 Market Overview
- 16.2.1 Region Information
- 16.2.2 Market Information
- 16.2.3 Background Information
- 16.2.4 Government Initiatives
- 16.2.5 Regulations
- 16.2.6 Regulatory Bodies
- 16.2.7 Major Associations
- 16.2.8 Taxes Levied
- 16.2.9 Corporate Tax Structure
- 16.2.10 Major Companies
16.3 Middle East Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.4 Middle East Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.5 Middle East Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

17.1 Summary
17.2 Market Overview
- 17.2.1 Region Information
- 17.2.2 Market Information
- 17.2.3 Background Information
- 17.2.4 Government Initiatives
- 17.2.5 Regulations
- 17.2.6 Regulatory Bodies
- 17.2.7 Major Associations
- 17.2.8 Taxes Levied
- 17.2.9 Corporate Tax Structure
- 17.2.10 Major Companies
17.3 Africa Constipation Treatment Market, Segmentation By Therapeutic Types, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.4 Africa Constipation Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.5 Africa Constipation Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

18.1 Company Profiles
18.2 Abbvie Inc
- 18.2.1 Company Overview
- 18.2.2 Products And Services
- 18.2.3 Business Strategy
- 18.2.4 Financial Overview
18.3 Bausch Health Companies Inc. (TRULANCE(R))
- 18.3.1 Company Overview
- 18.3.2 Products And Services
- 18.3.3 Business Strategy
- 18.3.4 Financial Overview
18.4 Ironwood Pharmaceuticals Inc. (LINZESS)
- 18.4.1 Company Overview
- 18.4.2 Products And Services
- 18.4.3 Business Strategy
- 18.4.4 Financial Overview
18.5 Ardelyx Inc
- 18.5.1 Company Overview
- 18.5.2 Products And Services
- 18.5.3 Financial Overview
18.6 Procter & Gamble Co
- 18.6.1 Company Overview
- 18.6.2 Products And Services
- 18.6.3 Financial Overview

19 Other Major And Innovative Companies

19.1 Boehringer Ingelheim International GmbH
- 19.1.1 Company Overview
- 19.1.2 Products And Services
19.2 Takeda Pharmaceutical Company Ltd.
- 19.2.1 Company Overview
- 19.2.2 Products And Services
19.3 Abbott Laboratories
- 19.3.1 Company Overview
- 19.3.2 Products And Services
19.4 Cipla Ltd.
- 19.4.1 Company Overview
- 19.4.2 Products And Services
19.5 Fresenius SE
- 19.5.1 Company Overview
- 19.5.2 Products And Services
19.6 Bayer AG
- 19.6.1 Company Overview
- 19.6.2 Products And Services
19.7 Lupin Ltd.
- 19.7.1 Company Overview
- 19.7.2 Products And Services
19.8 Norgine
- 19.8.1 Company Overview
- 19.8.2 Products And Services
19.9 Mallinckrodt Plc
- 19.9.1 Company Overview
- 19.9.2 Products And Services
19.10 Sun Pharmaceutical Industries Ltd.
- 19.10.1 Company Overview
- 19.10.2 Products And Services
19.11 Prestige Consumer Healthcare Inc. (C.B. Fleet)
- 19.11.1 Company Overview
- 19.11.2 Products And Services
19.12 Sanofi S.A.
- 19.12.1 Company Overview
- 19.12.2 Products And Services
19.13 GlaxoSmithKline plc (GSK plc)
- 19.13.1 Company Overview
- 19.13.2 Products And Services
19.14 Shionogi & Co. Ltd.
- 19.14.1 Company Overview
- 19.14.2 Products And Services
19.15 Prestige Consumer Healthcare Inc.
- 19.15.1 Company Overview
- 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

22.1 Grunenthal GmbH Acquired Valinor Pharma
22.2 Clinisupplies Ltd. Company Acquired Aquaflush Transanal Irrigation (TAI) Business from Renew Medical Ltd.

23 Recent Developments In Constipation Treatment

23.1 Introduction Of Novel Therapies To Enhance Chronic Constipation Management
23.2 Expansion Of Cost-Effective Treatment Options To Improve Accessibility In Constipation Care

24 Estimated Number Of Patients With Chronic Idiopathic Constipation (CIC) And Irritable Bowel Syndrome With Constipation (IBS-C) In Japan In 2024

25 Opportunities And Strategies

25.1 Constipation Treatment Market In 2029 - Countries Offering Most New Opportunities
25.2 Constipation Treatment Market In 2029 - Segments Offering Most New Opportunities
25.3 Constipation Treatment Market In 2029 - Growth Strategies
- 25.3.1 Market Trend Based Strategies
- 25.3.2 Competitor Strategies

26 Constipation Treatment Market, Conclusions And Recommendations

26.1 Conclusions
26.2 Recommendations
- 26.2.1 Product
- 26.2.2 Place
- 26.2.3 Price
- 26.2.4 Promotion
- 26.2.5 People

27 Appendix

27.1 Geographies Covered
27.2 Market Data Sources
27.3 Research Methodology
27.4 Currencies
27.5 The Business Research Company
27.6 Copyright and Disclaimer